Phreesia CEO's Third Win Highlights a Two-Decade Quest for Efficiency

WILMINGTON, Del. – February 11, 2026 – For the third time, Chaim Indig, the co-founder and CEO of Phreesia, has been named to The Software Report’s prestigious list of the Top 50 CEOs of 2025. The recurring recognition is more than a personal accolade; it serves as a powerful symbol of the sustained impact his company has had on the often-cumbersome U.S. healthcare system.

While awards in the fast-paced software industry can sometimes feel fleeting, Indig's consistent presence on the list points to a deeper story of long-term vision and execution. The award, which gathers nominations from industry peers and leaders, evaluates CEOs on their ability to deliver customer value, lead mission-driven teams, and drive organizational growth—metrics that Phreesia appears to be meeting with remarkable consistency.

“I’m truly honored to receive this recognition,” Indig stated in a press release. “To me, it’s a testament to our team’s tireless work to support healthcare organizations and their patients, and to achieve our mission of making care easier every day.”

This honor is part of a broader pattern of recognition for the company. Phreesia itself was named to The Software Report’s Top 50 Software Companies of 2025 for the fourth consecutive year, placing it among industry heavyweights. This dual acknowledgment of both the leader and the organization highlights a synergy that has been nearly two decades in the making.

The Architect of a Digital Front Door

When Chaim Indig co-founded Phreesia in 2005, the healthcare landscape was vastly different. The now-ubiquitous concepts of patient activation and digital-first engagement were still nascent. Indig's vision was to replace the cumbersome clipboard and paper forms that defined the patient check-in process with a streamlined, digital experience. This simple but profound idea became the foundation for a company that would eventually become a publicly traded leader in the health-tech space.

Under Indig's continuous leadership, Phreesia has evolved from a startup focused on intake to a comprehensive SaaS platform. Today, the company offers a suite of solutions for patient registration, scheduling, payments, and clinical outreach. This transformation from a niche solution to an integrated platform has been pivotal to its success, allowing it to become deeply embedded in the workflows of its clients. The company's journey to becoming a publicly traded entity on the New York Stock Exchange (NYSE: PHR) solidified its position as a serious player in the healthcare technology market.

Indig’s long tenure is an anomaly in a tech world often characterized by rapid CEO turnover. His steady hand has guided Phreesia through significant industry shifts, including the widespread adoption of electronic health records (EHRs) and the recent explosion in telehealth. Rather than being disrupted, Phreesia positioned itself as a vital partner, with a platform designed to integrate seamlessly with hundreds of EMR and practice management systems, thereby enhancing, not replacing, a provider's core technology stack.

Beyond the Award: Powering the Patient Experience

The true measure of Phreesia's success, and the reason for Indig's repeated accolades, lies in the platform's tangible impact. In 2024 alone, the company's software facilitated approximately 170 million patient visits. This staggering figure, representing more than one out of every seven patient visits across the United States, demonstrates the scale at which Phreesia is reshaping the healthcare experience.

The company supports over 4,400 healthcare organizations, from small private practices to large, multi-specialty hospital systems. For these providers, the platform is a powerful tool for driving operational efficiency. By digitizing and automating administrative tasks, Phreesia helps reduce staff burnout, minimize data entry errors, and accelerate revenue collection. This focus on the provider's bottom line is a key part of its value proposition.

Independent industry analysis validates these claims. KLAS Research, a leading healthcare IT data and insights firm, has identified Phreesia as the leader in patient intake management, noting its expansive market share and the depth of its adoption. Furthermore, the company earned a spot on G2's 2025 Best Software Awards for Healthcare Products, an honor based entirely on authentic reviews from verified users, suggesting that the platform’s real-world performance lives up to its marketing promises.

Navigating a Competitive and Evolving Market

Sustaining excellence in the competitive software-as-a-service market requires more than just a good product; it demands strong financial stewardship and a clear growth strategy. Phreesia's recent performance indicates it has both. For the fiscal year ending in January 2025, the company reported total revenue of $419.8 million, an impressive 18% increase from the previous year.

Perhaps more telling is the company's progress toward profitability. Phreesia significantly narrowed its net loss from $136.9 million in fiscal 2024 to $58.5 million in fiscal 2025. It also achieved a positive Adjusted EBITDA of $36.8 million, a dramatic turnaround from a negative $35.4 million the prior year. This financial discipline, coupled with a projected revenue of approximately $477 million for fiscal 2026, has earned it a “Moderate Buy” rating from market analysts.

This performance is especially noteworthy given the challenging economic climate and the inherent complexities of the healthcare industry. Phreesia's ability to not only grow but also improve its financial health speaks to the resilience of its business model and the non-negotiable value it provides to its clients. As healthcare organizations continue to face financial pressures and staffing shortages, the need for solutions that drive efficiency and enhance patient payments only becomes more critical.

The consistent recognition from bodies like The Software Report and The Healthcare Technology Report, which also recently named Indig a Top Executive of 2025, solidifies the narrative. These awards are not just celebrating a single year of success, but a nearly two-decade-long commitment to a singular mission: making healthcare easier for everyone involved. In a sector defined by complexity, that sustained focus may be Chaim Indig's and Phreesia's most significant achievement.